QIR Suite vs Lung AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

QIR Suite

by CASIS Cardiac Simulation & Imaging Software

Lung AI

by Exo

AI Verdict

QIR Suite is an AI-based software for detailed quantitative analysis of cardiovascular conditions using MR and CT images, deployed locally. Lung AI, conversely, is an integrated handheld ultrasound platform with AI for real-time cardiac and lung scanning, offering on-device processing and guided image capture. While both leverage AI for cardiac imaging, their distinct imaging modalities and deployment models make them suitable for different clinical workflows and use cases.

Choose QIR Suite if…

Choose QIR Suite if your clinical practice requires comprehensive, quantitative analysis of pre-acquired MR and CT images for detailed cardiovascular assessment. This tool is ideal for specialists needing to quantify over 100 clinical parameters, including blood flow, pathological volumes, and myocardial strain, to support precise diagnosis and prognosis in a dedicated imaging analysis environment.

View QIR Suite →

Choose Lung AI if…

Choose Lung AI if you need a portable, real-time, AI-powered ultrasound solution for immediate point-of-care assessment of cardiac and lung conditions. This tool is particularly well-suited for emergency medicine, critical care, or situations demanding rapid bedside evaluation and AI-guided image capture to quickly detect conditions like pleural effusion or consolidation.

View Lung AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	QIR Suite	Lung AI
Pricing	Contact for pricing	Contact for pricing
Deployment	Locally on dedicated hardware	On-device (integrated with Exo Iris handheld ultrasound device)
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Tool B emphasizes an 'easy-to-use medical imaging' experience with its handheld platform, 'guided image capture,' and 'real-time feedback,' indicating a strong focus on intuitive design and accessibility for point-of-care use. In contrast, Tool A requires local deployment on dedicated hardware, suggesting a potentially more specialized setup and workflow.

Clinical Value

QIR Suite

Tool A offers deep, quantitative analysis of MR and CT images, capable of quantifying over 100 clinical parameters, which is crucial for comprehensive diagnosis and prognosis of complex cardiovascular conditions. While Tool B provides valuable real-time, AI-powered insights for common lung and basic cardiac conditions at the point of care, its scope for detailed quantitative analysis appears more limited compared to Tool A's extensive capabilities.

Pricing & Value

QIR Suite

Tool A provides more transparency by outlining its pricing models as either a 'One-time license fee' or 'Subscription,' giving potential buyers a clearer understanding of how the software can be acquired. Tool B only states 'contact for pricing' with 'Not available' for pricing details, offering less insight into its cost structure.

Enterprise Readiness

Lung AI

Tool B explicitly states 'has_baa: yes' and 'hipaa_compliant: yes,' which are fundamental requirements for healthcare enterprises regarding data security and privacy. Its on-device AI processing further enhances data control, whereas Tool A lacks specified HIPAA compliance or BAA information and requires local hardware deployment, potentially posing more integration challenges.

Innovation

Lung AI

Tool B's pioneering approach of integrating powerful AI into a high-performance, handheld ultrasound platform for real-time, on-device processing and guided image capture represents a significant innovation in democratizing point-of-care imaging and AI accessibility. Tool A, while offering advanced quantitative analysis, primarily enhances existing diagnostic workflows for established imaging modalities.

Support & Docs

Lung AI

Tool B explicitly mentions 'Exo U (AI-powered POCUS education and training),' demonstrating a clear commitment to user education and ongoing support, which is crucial for effective adoption and utilization. Tool A provides no information regarding its support or documentation offerings in the provided facts.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	QIR Suite	Lung AI
Name	QIR Suite	Lung AI
Company	CASIS Cardiac Simulation & Imaging Software	Exo
Description	QIR Suite is an AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis.	Exo is pioneering a high-performance, handheld ultrasound platform that uses artificial intelligence for imaging and therapeutic applications. By delivering affordable, easy-to-use medical imaging, Exo empowers healthcare professionals around the world to make critical, real-time decisions that improve patient outcomes.
Key Features	AI-based analysis of MR and CT examinations, Detection of heart regions and pathological areas, Quantification of over 100 clinical parameters, Automatic segmentation, Blood flow/velocities quantification, Pathological volumes detection and quantification, Semi-quantification of myocardial perfusion, Strain quantification	AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis, Real-time feedback and image quality monitoring (SweepAI), Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy), Guided image capture for optimal scans, On-device AI processing (operates without internet), Pulsed-wave Doppler capabilities (on Exo Iris), Exo U (AI-powered POCUS education and training)

Videos

Demos, reviews, and walkthroughs featuring QIR Suite and Lung AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

QIR Suite is designed for analysis of MR and CT images and supports client/server functionalities to connect to a PACS (Picture Archiving and Communication System) and an HL7 server for image transfer and results reporting. Lung AI, integrated with the Exo Iris handheld ultrasound device, processes data on-device without internet, and its integration would focus on how real-time findings and captured images are transferred to the patient's EHR, potentially through its collaboration software.

For which specific clinical scenarios or specialties would each tool be most beneficial?

QIR Suite is tailored for detailed quantitative analysis of cardiovascular conditions from MR and CT scans, making it ideal for cardiologists and radiologists requiring in-depth diagnostic and prognostic insights for conditions like myocardial infarction or hypertrophic cardiomyopathy. Lung AI, with its handheld ultrasound and real-time AI, is particularly suited for emergency medicine, pulmonology, and cardiology for point-of-care diagnostics such as detecting pleural effusion, consolidation/atelectasis, or assessing cardiac conditions like heart failure rapidly at the bedside.

What is the expected learning curve for physicians and staff, and what training resources are available for each tool?

QIR Suite integrates with existing imaging modalities, and its software ergonomics have been optimized with clinician feedback to save time. Lung AI emphasizes ease of use with features like guided image capture (SweepAI) and offers 'Exo U' for AI-powered POCUS education and training, suggesting a focus on supporting users in mastering handheld ultrasound techniques and AI interpretation, even for novices.

How can physicians assess the clinical accuracy and sensitivity of the AI algorithms for the specific conditions each tool targets?

Physicians would typically look for published clinical validation studies or data demonstrating the accuracy and sensitivity of QIR Suite's quantitative analysis for cardiovascular MR/CT parameters. For Lung AI, clinical studies have shown high accuracy for detecting pleural effusion (sensitivity 0.967, specificity 0.912) and consolidation/atelectasis (sensitivity 0.968, specificity 0.945), with AI assistance improving clinician performance.

Beyond standard compliance, what are the key security features and data handling protocols that differentiate these tools?

QIR Suite's local deployment on dedicated hardware implies data processing and storage occur within the institution's controlled environment, which can offer specific security advantages. Lung AI features on-device AI processing that operates without an internet connection, significantly reducing external data transmission risks and enhancing data security at the point of care.

What audit trail capabilities do these tools offer to ensure accountability and track changes in AI-generated analyses or reports?

For QIR Suite, audit trails would likely track user interactions, parameter adjustments, and the generation of automated analysis reports, which can be stored on a PACS or HL7 server. For Lung AI, audit trails would focus on tracking image acquisition, real-time AI interpretations, and any user modifications made during or after the scanning process, with a need to document AI model versions and human review sign-offs for compliance.

What are the practical considerations for deploying and managing these tools across multiple clinical sites or departments?

QIR Suite's requirement for local deployment on dedicated hardware suggests that multi-site rollouts would involve hardware procurement and installation at each location. Lung AI, being integrated into a handheld device with on-device AI processing, offers greater portability and potentially simpler distribution across multiple sites or departments, with management focused on device inventory and software updates.